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Studies on mesangial IgA glomerulonephritis. J. Berger, Institut
National de Ia Sauté et de Ia Recherche Medicale, Unite 25, Hôpital
Necker, Paris, France. Mesangial IgA glomerulonephritis is an impor-
tant cause of terminal renal failure because it accounts for 10% of the
renal transplantations performed in France. Unfortunately, the patho-
genesis of this disease remains unknown. The data contributed by our
group to this problem are as follows: (1) Frequent recurrence of the
disease after renal transplantation; (2) rapid disappearance of the
deposits after the graft of a kidney from a cadaver donor with
unsuspected IgA nephntis; (3) occurrence of the disease in two identical
twins; (4) prevalence of DR4 antigen; (5) Bw35 as a marker for severe
forms; (6) statistically significant increase in the level of serum IgA; (7)
increase in serum IgA polymers correlated with the level of serum IgA;
(8) increased binding of IgA in the serum of Raji cells and to conglutinin;
(9) no shared idiotype between serum IgA from common cases of IgA
nephritis and the monoclonal IgA isolated from the serum of one patient
with IgA nephritis and a benign IgA monoclonal gammapathy; (10)
diminished suppressor cells/helper cells ratio; (11) normal in vitro
secretion of IgA by blood lymphocytes stimulated by pokeweed mito-
gen; (12) normal alternative complement pathway.
Prognosis of adult, primary IgA-nephropathy (IGAN). J. R. Beukhof,
J. Anema, L. M. Halie, G. J. Fleuren, and G. K. van der Hem.
University Hospital, Groningen, The Netherlands. IGAN is an elusive
disease: Much controversy exists about definition, pathogenesis and
prognosis. The course is reported of 74 patients, diagnosed as adult,
primary IGAN between 1967 and 1983, with a median follow-up of 75
months (diagnosis was based on predominantly mesangial IgA-deposi-
tions with exclusion of other glomerulopathies as found in SLE, HSP,
and cirrhosis). Creatinine clearance decreased below 20 mI/mm in 13
patients, necessitating dialysis treatment in ten. The change of GFR as
measured by constant infusion of iothalamate was not related to the
time interval elapsed (N = 26 patients). By plotting 1/ [creatinine] and
log [creatinine] versus time for the 16 patients, whose serum [creati-
nine] more than doubled, we concluded to a loss of a constant number
of nephrons per unit of time in seven; one lost a constant fraction of
nephrons; one decreased linearly or exponentially; and seven decreased
discontinuously (plateaux 9 months). Actuarial kidney survival was
80% after 10 years (from the first manifestation) and 72% after 20 years.
Actuarial kidney survival was in univariate analysis significantly corre-
lated with proteinuria, hypertension, first measured serum creatinine
and with interstitial infiltrate, tubular atrophy, and global sclerosis in
the renal biopsy specimens. No correlation was found with intake
hematuria and other light microscopical abnormalities (including me-
sangial and extracapillary proliferation and synechiae). As actuarial
survival also clearly depended on the following clinical criteria, we
propose to divide lOAN into subclass I, no gross hematuria; subclass 2,
typical attacks of gross hematuria with systemic symptoms (fever,
myalgia, malaise, and so forth); and subclass 3, moderate macroscopi-
cal hematuria, worsening after exertion, without systemic complaints.
Circulating macromolecular IgA-1 and mesangial secretory compo-
nent-binding IgA-l in primary IgA nephropathy. R. M. Valent(jn, I.
Radl, J. J. Haaiman, M. R. Daha, and L. A. van Es. Department of
Nephrology, University Hospital, Leiden, and Institute of Experimen-
tal Gerontology, TNO, R(jswzjk, The Netherlands. In a prospective
study of 35 patients with micro- or macrohematuria of renal origin
circulating immune complexes were determined by the 25l-Clq binding-
assay (CIqBA), the conglutinin binding-assay (ConBA), and the anti-
IgA inhibition of binding assay (a-IgA-InhBA). Results were related to
the histopathological findings on renal biopsy. Primary IgA-nephrop-
athy (prim. IgA-n) was found in 14 patients (group I), while the
remaining 21 patients showed a variety of renal diseases (group 2). With
the CIqBA negative results were obtained for all patients, while for the
ConBA 30% of the patients in each group had positive results. With the
a-lgA-InhBA circulating macromolecular IgA was found exclusively in
patients with prim. lgA-n (12 out of 14 patients). In these patients the
subclasses of IgA in the mesangium and the circulating macromolecular
IgA were determined, respectively, by immunofluorescence (IF) and
ELISA techniques, using monoclonal antibodies against IgA-l and IgA-
2. All biopsy specimens showed mesangial deposition of only IgA-l.
FITC-conjugated antisera against i-chain and secretory component
(SC) gave negative results. However, the deposited lgA-l was capable
of binding FITC-conjugated pure S.C. Gelfiltration fractionation of sera
from 13 patients with prim. IgA-n showed an increased amount of IgA-
1, in the 11 S region, which possessed the capacity to bind S.C. in a
solid-phase radioimmunoassay. In conclusion, the finding of macromo-
lecular IgA in the circulation of our patients with hematuria is highly
indicative of prim. IgA-n and precludes the need for invasive diagnostic
procedures. Mesangial IgA and circulating macromolecular IgA belong
both to the subclass IgA-1, are capable of binding S.C., and represent
probably dimeric IgA- I.
IgA nephropathy and ankylosing spondylitis. F. J. H. M. van Lieber-
gen, K. J. M. Assmann, R. A. P. Koene, and L. B. A. van de Putte.
Department of Medicine, Grootziekengasthuis Den Bosch and Depart-
ments of Pathology, Nephrology, and Rheumatology, Situ Radboud-
hospital, Nijmegen, The Netherlands. Serum IgA levels are often raised
in patients with ankylosing spondylitis which has led to speculations
about a role for IgA in the pathogenesis of this disease. New evidence
for such a role stems from sporadic observations of IgA nephropathy in
these patients. We have seen four male patients with this combination
of diseases. All were positive for the HLA-B27 antigen and had typical
changes in the sacroiliac joints on x-ray examination. The presence of
proteinuria (0.9 to 4.0 g/24 hr) and hematuria with red cell casts in the
urinary sediment was the reason to perform a renal biopsy. In each
patient there was a focal glomerulonephritis with extensive mesangial
deposition of IgA on immunofluorescence. All patients had raised lgA
levels. Skin biopsy specimens did not show IgA deposits. One patient
had a decreased creatinine clearance (33 mI/mm). Two patients could be
followed during 7 and 10 years, respectively. Their renal function
remained normal during this period. The results demonstrate a relation-
ship between IgA nephropathy and ankylosing spondylitis. It seems
likely that IgA antibodies or IgA-containing immune complexes play a
pathogenetic role in both conditions.
Is the proteinuria of IgA-nephropathy a clue to its pathogenesis? J. R.
Beukhof, M. Haas, G. J. Fleuren, A. f.M. Donker, G. K. van derHem,
and T. Ockhuizen. University Hospital, Groningen, The Netherlands.
In patients with IgA-nephropathy (IGAN) many immune abnormalities
have been described, the pathogenetic role of which has remained
unclear, mostly because an inverse experiment to determine how much
"abnormality" is necessary to cause a preset level of disease is not
feasible in humans. So no formal proof has been given of one of the four
mutually complementary, and encompassing hypotheses, about the
mechanism of IgA-deposition: (1) supply from the circulation of solu-
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ble, carried, or in situ formation of immune complexes; (2) decreased
mesangial clearance; (3) local synthesis; (4) increased flux due to
mediator/hemodynamics. We favor the last hypothesis because (1) IgA-
deposition is dissociated from nephritic symptoms; (2) 20 to 40% of the
IGAN-patients have a propensity to urticarial reactions; (3) high
synthesis of a lymphokine (vaso-permeability-factor) has been found in
IGAN; (4) IGAN patients (N = 15) had a selective proteinuria, when
protein excretion 0.5 g/24 hr and creatinine clearance >22 mI/mm; this
selectivity was determined via the selectivity index (IgG-clearance/
albumin-clearance) and by a Joachimplot of the clearance of IgG,
transferrin, and albumin. According to electron microscopy, protein-
una was not associated with mesangial or subepithelial deposits but
solely with subendothelial deposits. In conclusion, we wonder whether
a mediator disturbs the endothelial anionic sites, thus causing selective
proteinuna via impairment of the charge barrier and opening the way to
subendothelial and mesangial deposition of immune complexes. We
cannot, however, exclude the alternative hypothesis that immune
complexes, which are somehow deposited subendothelially, damage
the charge barrier thus causing selective proteinuria.
Plasma exchange (PE) in three patients with rapidly progressive
Henoch-SchOnlein glomerulonephritis (H-S GN). J. Clement, E. Stevens,
and R. M. Valent,jn. St. August inus Hospital, Antwerp, University
Hospital, Louvain, and University Hospital, Leyden, The Netherlands.
Three patients with rapidly progressive H-S GN are reported. In the
three kidney biopsy specimens, the immunofluorescence study gave a
predominantly IgA pattern, mainly pericapillary. The diagnosis of H-S
GN was confirmed by significantly positive serum levels of IgA-
containing immune complexes (IgA-IC), detected by a specific anti-
IgA-mnhibition binding assay (s-IgA-lnhBA), and of C3d, a degradation
product of C3. The three patients were resistant to treatment with
corticosteroids and/or cyclophosphamide. An improvement (patient I)
and at least a stabilization of renal function (patient 2) was obtained
with intermittent PE, which was each time correlated with a normaliza-
tion of C3d. The clinical course, however, was not correlated with the
serum levels of IgA-IC. In conclusion, (1) a-IgA-InhBA is a relevant
test for confirming the diagnosis of IgA-nephropathy. (2) Determination
of C3d gives a better evaluation of C3-consumption (by alternate and/or
classical pathway) than C3 and C4 and can be used for clinical
monitoring during therapeutic PE.
Renin-angiotensin-aldosterone system (RAAS) in infancy and childhood
in basal conditions and after stimulation. T. Fiselier, L. Monnens, P. van
Munster, M. Jansen, P. Peer, and P. Lzjnen. Departments of Pediatrics
and Statistical Consultation, University of Nzjmegen, The Netherlands,
and Hypertension and Cardiovascular Rehabilitation Unit, Department
of Pathophysiology, University of Leuven, Belgium. Plasma renin
activity (PRA), aldosterone (PA), sodium (Na), and potassium (K)
concentration were simultaneously measured in 107 infants and chil-
dren, aged I week to 16 years, in basal conditions of normal diet and
recumbency. Plasma angiotensin I and II (Al, All) and angiotensin-
converting enzyme (ACE) activity were also measured in 55 of them,
and urinary aldosterone (UAIdO), Na, and K in 51. Geometric mean
(med) and range for PRA, PA, Al and Al! are tabulated.
PRA
(ngA I/ml/hr) PA (ng/dl) Al (pg/mi) All (pg/mi)
Age N Med Range Med Range N Med Range Med Range
1w—3m 15 9.8 4.0—23.8 66 25—213 9 302 161—468 58 30—117
3—12 m 32 4.5 1.5—10.2 24 7—108 16 157 94—244 37 12—82
l—4yr 20 4.4 1.7—11.8 16 3—77 11 133 83—312 27 8—93
4—8yr 17 2.9 0.9—9.2 14 5—44 9 99 63—183 20 6—51
8—l6yr 19 2.0 0.9—7.6 10 4— 22 10 100 70—212 22 12—67
A significant (P < 0.001) age-related decrease in PRA (r =
—0.67), Al (r
=
—0.72), All (r = —0.51), PA (r = —0.67), and UAIdO (r = —0.56) was
observed, with a striking scatter of values especially in infancy. No
correlation was found between ACE and age (r = 0.26, P = 0.06). After
correction for age the partial correlations between PRA and PA (r =
0.30) or Al (r = 0.70), or PA and All (r = 0.38), or Al and All (r = 0.76)
were still significant (P < 0.01). No indication was found for an age-
related conversion of Alto All. The RAAS was also studied (N = 40)
after stimulation by standardized Na restriction (10 mmoles Na/I .73 m2/
day) during 4 days, followed by acute postural change of 90 mm sitting
posture. After salt restriction a rise of PRA and UAIdO was noted,
but a rise of PA could not be demonstrated in children aged I week to 6
months. The influence of postural change on the RAAS seems more
important in older children. These basal and stimulated values allow us
to study the RAAS in diseases such as salt loss and hypertension.
Intrarenal sodium handling in DahI "R" and "S" rats. J. C. Roos, K.
A. Kirchner, J. D. Abernethy, H. G. Langford. Department of Endocri-
nology and Hypertension, University of Mississippi Medical Center,
Jackson, Mississippi. It is known from Tobian's work that isolated
perfused salt-sensitive ("S") kidneys excrete 50% less Na than "R"
(salt-resistant) kidneys for any given perfusion pressure. The precise
tubular localization for this difference in Na handling is not known. To
elucidate this problem, normotensive 'S" and 'R" rats were acutely
volume-expanded with isotonic NaCI solution (25 mI/kg body weight)
during 30 mm and changes in intrarenal Na handling were measured.
Lithium was administered intraperitoneally 4 hr prior to the study (0.8
mI/kg isotonic LiCI i.p.). Fractional excretion of lithium (FEL,) was
used as a marker for proximal sodium reabsorption. Baseline values for
body weight, mean arterial pressure, glomerular filtration rate (GFR),
urinary sodium excretion (UNaV), FELl, and (calculated) absolute
amounts of proximal (PRNa) and distal reabsorption (DRNa) were
comparable for both strains. During volume loading UNV, FELl, distal
delivery of sodium (DDNa) and DRNa increased to a significantly
greater extent in "R" rats than "S" rats. Although the difference in
GFR did not reach significance, "R" rats showed a greater increase in
GFR. We concluded from these results that, also in vivo, normotensive
"S" rats excrete a volume load less rapidly. This is mainly due to less
delivery of Na out of the proximal tubule as the consequence of less
suppression of proximal Na reabsorption and probably also due to less
filtration. Therefore, if these results are to be applied to essential
hypertensive patients, we must assume that in these patients Na intake
is excessive because their kidneys cannot handle these amounts of Na
(unless hypertension develops).
C3 nephritic-factor-like stabilization of the amplification convertase of
complement by monoclonal antibodies directed against human factor B.
M. R. Daha, A. M. Deelder, and L. A. van Es. Department of
Nephrology and Parasitology, Universital Hospital Leiden, The Neth-
erlands. Chronic activation of the alternative pathway of complement
may be found in sera of patients with membranoproliferative glomerulo-
nephritis (MPGN type II) and in patients with partial lipodystrophy
(PLD). It has been reported earlier that an IgG autoantibody (C3
nephritic factor = C3Nef) directed against the amplification convertase
of complement, C3bBb, is able to stabilize the otherwise labile C3
convertase by preventing decay-dissociation of Bb from the convertase
and the inactivating action of the plasma protein H. In a study
performed with C3Nef isolated from the sera of ten patients with
MPGN, it was found that nine out of ten C3Nef preparations reacted
with C3b-bound Bb. In one case the C3Nef preparation contained both
specifications for C3b and C3b-bound Bb. In the present investigation
we investigated whether ornot monoclonal antibodies (MoAb) directed
against B are able to induce stabilization of cell-bound C3bBb and thus
have C3Nef-iike activity. MoAb were prepared by fusion of spleen cells
from Balb/c mice, immunized with purified human B, with SP2/0 mouse
myeloma cells. Positive clones were detected by their capacity to
induce stabilization of erythrocyte (E)-bound C3bBb. For this purpose,
cell-bound C3bBb were prepared by the interaction of EC3b with
purified B and D. EC3bBb were then incubated with medium of culture
supernatants alone. Those cultures which prevented decay of cell-
bound C3bBb were propagated further. Two positive monoclonal
antibodies (MoAb) with C3Nef-like activity were finally obtained.
MoAb29-2D2-B was 2.5 times more active than 29-5B5-A in the
stabilization of EC3bBb. The stabilization of EC3bBb was dependent
on the dose of MoAb used, and the MoAb were additive in their
capacity to stabilize C3bBb. These results indicate that monoclonal
antibodies directed against human B have C3Nef-like activity and that
they are able to modulate the enzymatic activity of the complement
system.
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Disease-related abnormalities in reticulo-endothelial function in pa-
tients with systemic lupus erytbematosus, Wegener disease, and idiopath-
ic membranous glomerulopathy. F. J. van der Woude, H. Beekhuis, M.
van der Giessen, P. J. Hoedemaeker, T. H. The, and G. K. van der
Hem. Departments of Internal Medicine, Nuclear Medicine and Pa-
thology, State University, Groningen, The Netherlands. Reticulo-
endothelial function was studied in 12 patients with systemic lupus
erythematosus (SLE); eight patients exhibited Wegener granulomatosis
(WG) and 20 patients idiopathic membranous glomerulopathy (MGP).
Autologous 9'°Tc-labeled heat-damaged red cells were used. This
enabled quantitative organ scintigraphy. Blood clearance and spleen
uptake kinetics were normal. However, in patients with active SLE,
active WG, and MGP, a significant shift from spleen to liver uptake
occurred in comparison to the control group. This phenomenon was not
related to age, level of circulating immune complexes, complement
level, kidney function, or immunosuppressive treatment. We also
studied 18 patients with SLE with mTclabeled IgG-coated red cells.
The same donor cells were used in controls and patients. Thus, a good
standardization of the number of antibody molecules on the erythrocyte
surface could be achieved. These cells showed a bi-exponential blood
disappearance curve, attributable to a reversible and irreversible spleen
uptake. Liver uptake, depending on the degree of antibody coating,
could clearly be demonstrated. In two patients (the only two with major
disease activity), the T'/2 of the blood disappearance curve was pro-
longed. One patient had a decreased spleen uptake; the other patient
had a decreased liver uptake. No relation with age, sex, level of
circulating immune complexes, complement level, kidney function or
immunosuppressive treatment could be demonstrated. We conclude
that the two methods measure different receptors in spleen and liver.
MPS dysfunction cannot be attributed to a saturation of receptors by an
excess of circulating immune complexes in patients with SLE, WG, and
MGN.
Characterization of a vasoactive factor in normal rat serum which is
able to affect glomerular polyanion (GPA) in vitro. W. W. Bakker, M. J.
Hardonk, G. Roskam, J. T. W. M. Vos, F. W. J. Dijkhuis, and E.
Bleumink. Department of Pathology, University of Groningen and
Department of Dermatology of the University Hospital of Groningen,
The Netherlands. In a previous study it was shown that normal rat
serum contains an enzyme-like vasoactive factor which is able to affect
glomerular polyanion (GPA) in vitro. To characterize the active materi-
al, heat-inactivated serum of normal Wistar rats was dialyzed against
0.01 M Tris-HCI containing 0.01 M NaCI, pH 8.0, and run over a DE52
(Whatman) column at 4°C, using a linear NaCI gradient at pH 8.0.
Pooled and concentrated fractions were tested for their capacity to
affect GPA in vitro following a 2-hr incubation with kidney sections at
37°C and also in vivo for their capacity to induce increased vascular
permeability using a vascular permeability assay (VPA) in the rat.
Fractions eluting between 0.035 and 0.055 M NaCI showed activity in
both test systems and were pooled and dialyzed against phosphate-
buffered saline, pH 7.2, and run over a G150-SF Sephadex column (70
x 2.5 cm, flow rate 8 ml/hr). This resulted in the elution of two protein
peaks measured at 280 nm of which the second one showed activity in
both test systems in contrast to fraction I. Molecular weight (MW)
estimations using gradient polyacrylamide gel electrophoresis (PAGE)
of fraction 2 suggested a MW of 100 kilodalton. Inhibition studies were
performed using serine protease inhibitors including soybean trypsin
inhibitor (SBTI), €-aminocaproic acid (eACA), anti-thrombin III
(aThrom) and ovomucoid (OvoM), as well as with other agents includ-
ing pyridinocarbamate (pyr), methysergide (meth), and mepyramide
(mep). The agents were either incubated in vitro or injected intrader-
mally in vivo with or without the serum fractions, using several
concentrations (5 to 300 sg/ml), except for meth and pyr which were
injected intraperitoneally (I mg/mi) into the rats I hr before the vascular
permeability testing was performed. The results show that activity of
fraction 2 from the Gl50-SF column can be inhibited completely by 20
gIml SBTI or 20 sg/ml eACA, or aThrom (25 mU/mi), but not by
OvoM (10 to 300 sg/ml) when tested in vitro, whereas a similar
inhibition pattern could be observed using the VPA. In the VPA a
significant inhibition of °'°30% occurred by these protease inhibitors
except OvoM, meth, and mep, whereas pyr was able to inhibit the
response induced by fraction 2 up to 52% (P <0.01). None of the agents
tested without the serum fractions showed activity in the test systems
used. Enzymatic analysis with a series of synthetic chromogenic
(tripeptide) substrates revealed the presence of serine esterase (prote-
ase) activities with plasma kallikrein-like specificities. From the present
study combined with earlier observations, it is concluded that a kinin-
releasing system might be involved in both the in vitro and in vivo
effects observed.
Influence of progressive dietary salt restriction on uremic acidosis. E.
Matthys and N. Lameire. Renal Division, Department of Internal
Medicine, University Hospital, Gent, Belgium. After an NH4CI-loading
test, nine (group A) out of 23 uremic, acidotic patients (Ccr < 20 ml/
mm) demonstrated urinary acidification disturbances (mean UpH: 6.47
0.05 at a plasma HC03 level of 13.11 0.48 mEq/liter), due to a
persistent bicarbonaturia (mean fractional HC03 excretion of 1.40
0.26%). The other 13 patients (group B) showed, at the same plasma
HC03 level of 13.11 0.43 mEq/liter, an appropriately low UpH
(mean, 5.40 0.10) and no bicarbonaturia. Between these two groups,
there was no difference in creatinine clearance, plasma Na, K, Cl, F,
Pco2 and aldosterone levels. Group H however demonstrated a higher
PTH level (33.8 7.21 vs. 17.3 3.51 mU/dI; P < 0.05) and a higher
basal fractional Na excretion (FENa) (10.39 1.44 vs. 4.61 0.60%, P
<0.05) than group B. To test the hypothesis that the bicarbonaturia was
the consequence of the salt losing, four patients of group A, with a well-
documented salt losing nephropathy (FENa ranging from 10.20 to
15.10%) were subjected to a progressive dietary salt restriction over 6
weeks. The FENa decreased to a range of 1.08 to 1.76%, without
concomitant changes in the extracellular volume, PTH levels, or other
parameters influencing the tubular HCO3 reabsorption. At this stage,
the four patients presented bicarbonaturia no longer and appropriately
lowered their urinary pH (range, 5.l5 to 5.65) during NH4CI-induced
acidosis. Three of the four patients also demonstrated a slight increase
in their spontaneous plasma HC03. A repeated intravenous HC01
loading test revealed that, at normal plasma bicarbonate levels, one
patient reduced his net base excretion significantly and the other three
excreted net acid instead of net base, as found before the dietary salt
restriction. It is concluded that part of the acidosis in uremic patients
can be explained by severe and persistent bicarbonaturia. The latter is
related to the salt-losing tendency, frequently associated with intersti-
tial diseases. Reversal of the salt-losing state without concomitant
changes in the extracellular volume status results in disappearance of
the bicarbonaturia, increase in the net acid excretion, and partial
correction of the uremic acidosis.
